Skip to main content
Tech.euFundingExplorerBeta

RNatives

Finnish biotechnology company developing precision RNA-based gene regulating therapies

RNatives has raised €1.4M across 1 funding round from 3 investors, most recently a Seed round in May 2025. Based in Kuopio, Finland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€1.4M
€1,400,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-05
latest 2025-05

Funding by year

EUR raised per year
RNatives — funding by year — interactive chart.
Data table
RNatives — funding by year
2025€1.4M

Signals

High confidence
Raise-next likelihood57
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2025-05-27Seed€1.4MBusiness Finland,Force10,Nordic Science Investments (NSI)View deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData